Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Gerald J. Chader is active.

Publication


Featured researches published by Gerald J. Chader.


The Journal of Neuroscience | 1995

Expression, secretion, and age-related downregulation of pigment epithelium-derived factor, a serpin with neurotrophic activity

Joyce Tombran-Tink; Sunil M. Shivaram; Gerald J. Chader; Lincoln V. Johnson; Dean Bok

Retinal pigment epithelial (RPE) cells form a functional complex with photoreceptor neurons of the retina, interacting through the interphotoreceptor matrix (IPM). We now provide evidence that the gene for pigment epithelium-derived factor (PEDF), a protein possessing neurotrophic and neuronal-survival activities, is highly expressed by both fetal and young adult RPE cells. PEDF mRNA is present in RPE cells of the human eye at 17 weeks of gestation, demonstrating its potential for action in vivo during early retinal development. The PEDF protein is secreted in vivo where it constitutes a part of the fetal and adult IPM surrounding photoreceptor outer segments. A polyclonal PEDF antibody recognizes at least four isoforms of secreted human and bovine PEDF by two dimensional gel analysis, and detects a similar 50 kDa protein in the IPM of several other vertebrate species. Within soluble extracts of RPE cells, however, where little, if any, of the 50 kDa species can be detected, an immunoreactive 36 kDa protein is observed by Western blot analysis. By immunofluorescence, PEDF is localized intracellularly in association with the nucleus, presumptive secretory granules, and cytoskeletal elements of cultured RPE cells with PEDF and actin antibodies colocalizing to the same cytoskeletal structures. During initial stages of attachment, PEDF and actin also concentrate at the tips of pseudopods extended by the cultured RPE cells. However, with successive passages, synthesis, and secretion of the PEDF protein as well as transcription of its mRNA decrease and are lost by about 10 passages. In parallel, cultured RPE cells lose their proliferative potential and change from an epithelial-like morphology in early passages to a more fibroblast-like appearance by about the 10th passage. PEDF is thus apparently present intracellularly and extracellularly in both fetal and early adult periods where it could be involved in cellular differentiation and survival and with its loss, in the onset of senescence.


Journal of Autoimmunity | 1990

Pathology of experimental autoimmune uveoretinitis in mice

Chi-Chao Chan; Rachel R. Caspi; Ming Ni; William C. Leake; Barbara Wiggert; Gerald J. Chader; Robert B. Nussenblatt

The histopathology and immunopathology of murine experimental autoimmune uveoretinitis (EAU) following active immunization with the interphotoreceptor retinoid-binding protein (IRBP) were studied. The methods used included conventional light microscopy and immunoperoxidase staining. Lesions were located mainly in the uvea and the retina and were characteristically focal. The prominent histopathologic findings in the retina were vasculitis, granuloma, retinal fold, focal serous detachment, and loss of photoreceptors. Granulomas, formation of Dalen-Fuchs nodules, inflammatory cellular infiltration and increase in the thickness of the choroid and ciliary body were frequent findings. Subretinal neovascularization occurred in 10% of the experimental animals. Mild to moderate inflammation was also noted in the vitreous. The predominant infiltrating cells in the retinal and uveal granuloma and the Dalen-Fuchs nodules were macrophages. In contrast, the predominant infiltrating cell types in the vitreous were T helper/inducer lymphocytes. T suppressor/cytotoxic cells were rarely seen. Expression of Ia antigens on the ocular cells was confined to the immediate area of the inflammatory sites. The kinetics of histopathology showed two peaks at the 5th and 10th week after immunization, suggesting a relapsing course of the disease.


Molecular Neurobiology | 1993

Interphotoreceptor retinoid-binding protein (IRBP) - Molecular biology and physiological role in the visual cycle of rhodopsin

David R. Pepperberg; Ting Ing L Okajima; Barbara Wiggert; Harris Ripps; Rosalie K. Crouch; Gerald J. Chader

The regeneration of visual pigment in rod photoreceptors of the vertebrate retina requires an exchange of retinoids between the neural retina and the retinal pigment epithelium (RPE). It has been hypothesized that interphotoreceptor retinoid-binding protein (IRBP) functions as a two-way carrier of retinoid through the aqueous compartment (interphotoreceptor matrix) that separates the RPE and the photoreceptors. The first part of this review summarizes the cellular and molecular biology of IRBP. Work on the IRBP gene indicates that the protein contains a four-fold repeat structure that may be involved in binding multiple retinoid and fatty acid ligands. These repeats and other aspects of the gene structure indicate that the gene has had an active and complex evolutionary history. IRBP mRNA is detected only in retinal photoreceptors and in the pineal gland; expression is thus restricted to the two photosensitive tissues of vertebrate organisms. In the second part of this review, we consider the results obtained in experiments that have examined the activity of IRBP in the process of visual pigment regeneration. We also consider the results obtained on the bleaching and regeneration of rhodopsin in the acutely detached retina, as well as in experiments testing the ability of IRBP to protect its retinoid ligand from isomerization and oxidation. Taken together, the findings provide evidence that, in vivo, IRBP facilitates both the delivery of all-trans retinol to the RPE and the transfer of 11-cis retinal from the RPE to bleached rod photoreceptors, and thereby directly supports the regeneration of rhodopsin in the visual cycle.


American Journal of Ophthalmology | 1990

Cellular Immune Responses of Patients with Uveitis to Retinal Antigens and Their Fragments

Marc D. de Smet; Joyce Hisae Yamamoto; Manabu Mochizuki; Igal Gery; Vijay K. Singh; Tochimichi Shinohara; Barbara Wiggert; Gerald J. Chader; Robert B. Nussenblatt

Of two patient populations totaling 82 patients, one in the United States and the other in Japan, we studied the cellular immune responses against S-antigen and interphotoreceptor retinoid binding protein as well as to fragments of each antigen. Behçets disease, birdshot retinochoroidopathy, pars planitis, ocular sarcoid, sympathetic ophthalmia, and the Vogt-Koyanagi-Harada syndrome were diagnosed in these patients. The response profile of both antigens paralleled each other. This profile was more commonly seen in patients suffering from diseases affecting the retina. Responders reacting to both antigens or to several fragments of an antigen were present. This pattern of response was seen in 26 of the patients tested. Patients with uveitis appeared able to recognize several autoantigens. This might be a consequence of the breakdown of the blood-retinal barrier and may help perpetuate the inflammatory process. Several patients were capable of responding to more than one epitope of the same antigen, which indicates that there are major differences between the experimental model and human autoimmune diseases in the response to autoantigens. Both of these findings may to help develop new immunotherapeutic strategies in the treatment of uveitis.


Investigative Ophthalmology & Visual Science | 2010

Ophthalmic Drug Delivery Systems for the Treatment of Retinal Diseases: Basic Research to Clinical Applications

Henry F. Edelhauser; Cheryl Rowe-Rendleman; Michael R. Robinson; Daniel G. Dawson; Gerald J. Chader; Hans E. Grossniklaus; Kay D. Rittenhouse; Clive G. Wilson; David A. Weber; Baruch D. Kuppermann; Karl G. Csaky; Timothy W. Olsen; Uday B. Kompella; V. Michael Holers; Gregory S. Hageman; Brian C. Gilger; Peter A. Campochiaro; Scott M. Whitcup; Wai T. Wong

The basic science part of this article focuses on the anatomic barriers to the five major modes of ocular drug delivery: intraocular, periocular, hybrid, topical, and systemic. The second half is a review of the clinical and regulatory components of translational science.


Journal of Neurochemistry | 2002

Pigment epithelium-derived factor is a survival factor for cerebellar granule cells in culture

Takayuki Taniwaki; S. Patricia Becerra; Gerald J. Chader; Joan P. Schwartz

Abstract: Pigment epithelium‐derived factor (PEDF), purified from human fetal retinal pigment epithelium cell culture medium, was shown to potentiate the differentiation of human Y‐79 retinoblastoma cells. To investigate potential neurotrophic effects of PEDF on neurons other than those of retinal derivation, we used cultures of cerebellar granule cells. The number of cerebellar granule cells was significantly larger in the presence of PEDF, as demonstrated by an assay for viable cells that uses 3‐(4,5‐dimethylthiazol‐2‐yl)‐5‐(3‐carboxymethoxyphenyl)‐2‐(4‐sulfophenyl)‐2H‐tetrazolium, inner salt, conversion, by cell count, and by immunocytochemistry. The effect of PEDF showed a dose‐response relationship, with a larger effect in chemically defined medium than in serum‐containing medium [ED50 = 30 ng/ml (0.70 nM) in chemically defined medium and 100 ng/ml (2.3 nM) in serum‐containing medium]. PEDF had no effect on incorporation of bromodeoxyuridine (cell proliferation) or on neurofilament content (neurite outgrowth) measured by an enzyme‐linked immunoadsorbent assay. These results demonstrate that PEDF has a neurotrophic survival effect on cerebellar granule cells in culture and suggest the possibility that it may affect other CNS neurons as well.


Journal of Neuroscience Research | 1998

Pigment epithelium-derived factor (PEDF) differentially protects immature but not mature cerebellar granule cells against apoptotic cell death.

Takehisa Araki; Takayuki Taniwaki; S. Patricia Becerra; Gerald J. Chader; Joan P. Schwartz

We have shown previously that pigment epithelium‐derived factor (PEDF) acts as a survival factor for cerebellar granule cell neurons in culture, as well as protecting them against glutamate toxicity. In this study we have examined effects of PEDF on apoptotic cell death. We find that the granule cells die of apoptosis throughout the culture period, what we have termed “natural” apoptosis. PEDF prevents this natural apoptosis if added to immature cells, within the first 2 days in vitro (DIV), and the effect is maintained for up to DIV12. However, PEDF has no effect if added to mature cells at DIV5. Similar results are obtained when apoptosis is induced by shifting the cells from a serum‐ and 25 mM KCl‐containing medium to serum‐free medium with 5 mM KCl. PEDF most effectively blocks induced apoptosis in immature cells (DIV2) when added 24 hr prior to the change of medium, but still provides some protection when added simultaneously. However, 24 hr pretreatment with PEDF has a minimal effect when apoptosis is induced in mature DIV6 cells; addition at the same time is completely ineffective. Two polypeptide fragments of PEDF, only one of which contains the serine‐protease inhibitory site, are equally active, supporting previous results which suggest that the neurotrophic effects of PEDF are not mediated by protease inhibition. We conclude that PEDF protects immature but not mature granule cells against both natural and induced apoptosis. J. Neurosci. Res. 53:7–15, 1998. Published 1998 Wiley‐Liss, Inc. This article is a US Government work and, as such, is in the public domain in the United States of America.


Journal of Neurochemistry | 2002

Pigment epithelium-derived factor protects cultured cerebellar granule cells against glutamate-induced neurotoxicity.

Takayuki Taniwaki; Naohide Hirashima; S. Patricia Becerra; Gerald J. Chader; Rene Etcheberrigaray; Joan P. Schwartz

Abstract: Pigment epithelium‐derived factor (PEDF) is a survival factor for cerebellar granule cells in culture. In the present study, we have investigated the ability of a recombinant form of PEDF (rPEDF) to protect against glutamate neurotoxicity. When rPEDF was added to cerebellar granule cell cultures 30 min before addition of 100 µM glutamate, glutamate‐induced neuronal death was significantly reduced. The protective effect of rPEDF was dose‐dependent in the range from 0.023 to 7.0 nM (1–500 ng/ml), with a half‐maximal dose of 0.47 nM. An antibody to rPEDF blocked this protective effect. Measurement of intraneuronal free calcium levels demonstrated that rPEDF raised the basal calcium content. However, after the elevation of intracellular calcium in response to administration of glutamate, rPEDF reduced the plateau level seen in the presence of glutamate. These data show that PEDF can protect neurons against glutamate‐induced neurotoxicity, possibly via a calcium‐related pathway. The finding that only 30 min of preincubation is required for the neuroprotective effect, significantly faster than other known neurotrophic factors, suggests that PEDF may be useful clinically as a neuroprotective agent in the CNS.


Photochemistry and Photobiology | 1996

Retinoids and the Visual Process

Rosalie K. Crouch; Gerald J. Chader; Barbara Wiggert; David R. Pepperberg

Rosalie K. Crouch’’, Gerald J. Chader2, Barbara Wiggert2 and David R. Pepperberg3 ‘Departments of Ophthalmology and Biochemistry, Medical University of South Carolina, Charleston, SC, USA; 2Laboratory of Retinal Cell and Molecular Biology, National Eye Institute, Bethesda, MD, USA and 3Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago, College of Medicine, Chicago, IL USA


Photochemistry and Photobiology | 1992

INTERPHOTORECEPTOR RETINOID‐BINDING PROTEIN AND α‐TOCOPHEROL PRESERVE THE ISOMERIC AND OXIDATION STATE OF RETINOL

Rosalie K. Crouch; E. Starr Hazard; Thomas Lind; Barbara Wiggert; Gerald J. Chader; D. Wesley Corson

Retinol decomposes rapidly into a number of products, including its aldehyde form, retinal, when introduced into buffer in phospholipid vesicles or ethanol. Interphotoreceptor retinoid‐binding protein at low concentrations is found to protect retinol from isomerization and oxidation. The addition of α‐tocopherol to either liposomes or an ethanolic‐buffer solution also prevents decomposition. Neither of these agents interferes with the successful regeneration of pigment with 9‐cis retinal in rod outer segment preparations or the restoration of sensitivity by retinoids in isolated rod photoreceptors.

Collaboration


Dive into the Gerald J. Chader's collaboration.

Top Co-Authors

Avatar

Barbara Wiggert

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Mark S. Humayun

University of Southern California

View shared research outputs
Top Co-Authors

Avatar

Igal Gery

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Robert J. Waldbillig

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Ignacio R. Rodriguez

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Ling Lee

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

R. Theodore Fletcher

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Joyce Tombran-Tink

Pennsylvania State University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Timothy J. Schoen

National Institutes of Health

View shared research outputs
Researchain Logo
Decentralizing Knowledge